Solara Active Pharma Sciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Strong revenue growth in the latest quarter indicates increasing market demand for Solara's products.
Operating margin improvement suggests enhanced operational efficiency and cost management.
Investment in R&D is expected to yield innovative products, aligning with industry trends for growth.

NEGATIVES

Declining net profit margin in the latest quarter indicates rising costs that may impact profitability.
Increased debt levels could raise concerns about financial stability and future cash flow management.
Sales volatility observed over the past year poses risks to consistent revenue generation.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	425.24	248.73	299.43	363.49	346.95	300.31	273.01	319.15
Expenses	438.26	461.75	345.61	377.51	339.26	293.71	281.06	309.61
Operating Profit	-13.02	-213.02	-46.18	-14.02	7.69	6.60	-8.05	9.54
Other Income	1.18	0.45	1.70	0.56	0.32	1.49	5.95	0.98
Interest	24.44	25.37	30.69	30.87	28.28	26.54	29.12	23.90
Depreciation	26.21	25.96	25.25	25.07	25.34	24.54	24.30	23.58
Profit Before Tax	-17.06	-275.34	-166.66	-13.46	8.01	8.09	-2.10	10.52
Tax	0	0	88.79	0	0	0	0	0
Net Profit	-17.06	-275.34	-255.45	-13.46	8.01	8.09	-2.10	10.52
Eps in Rs	-4.77	-76.49	-70.93	-3.50	2.54	2.03	-0.93	2.46